by Backoffice | Apr 29, 2022 | Trial results
The objective of the phase I clinical trial was to evaluate safety and provide proof of concept for efficacy of allogeneic adipose tissue-derived mesenchymal stromal cells (ASCs) injected into the major salivary glands in cancer patients with salivary glands damaged...
